Central Nervous System Malignancies, An Issue of Hematology/Oncology Clinics of North America
- 1st Edition, Volume 36-1 - November 24, 2021
- Latest edition
- Editor: David A. Reardon
- Language: English
In this issue of Hematology/Oncology Clinics, guest editor David A. Reardon︎ brings his considerable expertise to the topic of Central Nervous System Malignancies. Top experts in… Read more
Purchase options
In this issue of Hematology/Oncology Clinics, guest editor David A. Reardon︎ brings his considerable expertise to the topic of Central Nervous System Malignancies. Top experts in the field cover key topics such as CNS Metastases, Leptomeningeal Disease, Neurofibromatoses, Imaging Advances for CNS Tumors, and more.
-
Contains 16 relevant, practice-oriented topics including CNS Tumor Classification: An Update on the Integration of Tumor Genetics; Etiology and Epidemiology of CNS Tumors; The Evolving Role of Neurosurgical Intervention for CNS Tumor ; Update on Radiation Therapy for CNS Tumors; and more.
-
Provides in-depth clinical reviews on CNS Malignancies, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Central Nervous System Tumor Classification: An Update on the Integration of Tumor GeneticsThe Epidemiology of Central Nervous System TumorsImaging Advances for Central Nervous System TumorsThe Evolving Role of Neurosurgical Intervention for Central Nervous System TumorsUpdate on Radiation Therapy for Central Nervous System TumorsIsocitrate Dehydrogenase Mutant Grade II and III Glial NeoplasmsIsocitrate Dehydrogenase Wild-type Glial Tumors, Including GlioblastomaBiology and Treatment of Meningiomas: A ReappraisalPrimary Central Nervous System LymphomasCentral Nervous System MetastasesLeptomeningeal DiseaseCentral Nervous System Complications Among Oncology PatientsIs There a Role for Immunotherapy in Central Nervous System Cancers?NeurofibromatosesNeurocognition and Health-Related Quality of Life Among Patients with Brain TumorsDisparities and Inequities Among Patients with Central Nervous System Tumor
- Edition: 1
- Latest edition
- Volume: 36-1
- Published: November 24, 2021
- Language: English
DR
David A. Reardon
Affiliations and expertise
Clinical Director
Center for Neuro-Oncology
Dana-Farber Cancer Institute
Boston, MA